Cytogenetics
细胞遗传学
基本信息
- 批准号:7944991
- 负责人:
- 金额:$ 9.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-17 至 2014-02-28
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelApplications GrantsCancer CenterCancer Center Support GrantCell Culture TechniquesCellsChromosome BreakageClinicalClonalityColorComprehensive Cancer CenterCultured CellsCustomCytogenetic AnalysisCytogeneticsCytogenetics Shared ResourceData AnalysesDevelopmentDiagnosticDiseaseEmbryoFibroblastsFluorescent in Situ HybridizationFreezingGenesGeneticGrantHereditary DiseaseHome environmentHumanHybrid CellsImageInterphaseLaboratoriesLocationMalignant NeoplasmsMapsMayo Clinic Cancer CenterMetaphaseMicroscopeMolecular CytogeneticsMonitorMusParaffin EmbeddingPatternProcessProductionPrognostic MarkerPublicationsResearchResearch PersonnelResource SharingSamplingScientistServicesSlideSpecimenSpectral KaryotypingSystemTechniquesTissue MicroarrayTissuesTransgenesTumor Cell LineVisual AidXenograft procedurecell typeestablished cell linefluorescence microscopemeetingsmembernerve stem cellnovelprogramsresearch studytumor
项目摘要
The central focus of the Cytogenetics Shared Resource (CSR) is to provide cytogenetic and molecular
cytogenetic analysis of human and animal model research samples. These samples may be in the form of
cultured cells, fresh or frozen tissue, paraffin-embedded sections, or tissue microarrays (TMAs). Specific cell
types include tumor cell lines, xenograft cells, hybrid cells from chimeric animal models, neural stem cells,
and mouse embryonic fibroblasts, among others. The CSR provides specialized services including cell
culture, routine cytogenetic analysis, chromosome breakage analysis, interphase and metaphase
Fluorescence in situ Hybridization (FISH), Spectral Karyotyping (SKY) analysis of human and mouse
metaphases, and homebrew FISH Probe Production. This last service provides novel FISH probes that are
specific to investigators needs and are usually not commercially available. These probes are then used for
FISH analysis studies. The CSR is expanding this service beyond homebrew enumeration FISH probes by
creating custom translocation/fusion probes, break-apart probes, and multi-color FISH probes to ultimately
assist in developing strategic probes that become clinical diagnostic and prognostic markers of disease.
Other services provided by the CSR to meet the needs of investigators include utilization of the CSR
laboratory for slide processing and fluorescent microscope and imaging system use. Briefly, applications of
CSR services include: to characterize the clonality of tumor specimens; to determine the origin of a specific
tumor culture (i.e., mouse vs. human), to aid in the identification of genetic regions important for the
development of specific malignancies, and to map the location of DMA sequences, genes, or transgene
insertions. With the recognition that cancer is a genetic disease, many cancer researchers, including
scientists in the Mayo Clinic Cancer Center (MCCC), require access to CSR services. This Shared Resource
is utilized by 9 of the 12 Cancer Center Programs. Approximately 66% of CSR users are CCSG members
and represent 92% of the overall utilization.
细胞遗传学共享资源 (CSR) 的中心重点是提供细胞遗传学和分子生物学
人类和动物模型研究样本的细胞遗传学分析。这些样本可以是以下形式
培养细胞、新鲜或冷冻组织、石蜡包埋切片或组织微阵列 (TMA)。特定细胞
类型包括肿瘤细胞系、异种移植细胞、来自嵌合动物模型的杂交细胞、神经干细胞、
和小鼠胚胎成纤维细胞等。 CSR提供专业服务,包括细胞
培养、常规细胞遗传学分析、染色体断裂分析、间期和中期
人类和小鼠的荧光原位杂交 (FISH)、光谱核型分析 (SKY)
中期和自制 FISH 探针生产。最后一项服务提供新颖的 FISH 探针
专门针对研究人员的需求,通常无法在商业上获得。然后这些探针用于
FISH 分析研究。 CSR 正在将这项服务扩展到自制枚举 FISH 探针之外:
创建定制易位/融合探针、分离探针和多色 FISH 探针,最终
协助开发成为疾病临床诊断和预后标志物的战略探针。
CSR 为满足调查人员的需求而提供的其他服务包括利用 CSR
实验室供载玻片处理以及荧光显微镜和成像系统使用。简而言之,应用
CSR 服务包括: 表征肿瘤样本的克隆性;以确定特定的来源
肿瘤培养(即小鼠与人类),以帮助识别对肿瘤重要的遗传区域
特定恶性肿瘤的发展,并绘制 DMA 序列、基因或转基因的位置图
插入。随着癌症是一种遗传性疾病的认识,许多癌症研究人员,包括
梅奥诊所癌症中心 (MCCC) 的科学家需要获得企业社会责任服务。此共享资源
12 个癌症中心项目中的 9 个使用该项目。大约 66% 的 CSR 用户是 CCSG 成员
占总体利用率的 92%。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT B. JENKINS其他文献
ROBERT B. JENKINS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT B. JENKINS', 18)}}的其他基金
UNDERSTANDING THE INTERACTIONS BETWEEN GERMLINE AND SOMATIC ALTERATIONS in the PATHOGENESIS OF GLIOMAS
了解胶质瘤发病机制中种系和体细胞改变之间的相互作用
- 批准号:
10625788 - 财政年份:2018
- 资助金额:
$ 9.99万 - 项目类别:
(PQ3) UNDERSTANDING THE INTERACTIONS BETWEEN GERMLINE AND SOMATIC ALTERATIONS in the PATHOGENESIS OF GLIOMAS
(PQ3) 了解胶质瘤发病机制中种系和体细胞改变之间的相互作用
- 批准号:
10475617 - 财政年份:2018
- 资助金额:
$ 9.99万 - 项目类别:
Identification of 9p and 20q Germline Alterations in Glioblastoma Pathogenesis
胶质母细胞瘤发病机制中 9p 和 20q 种系改变的鉴定
- 批准号:
7814535 - 财政年份:2009
- 资助金额:
$ 9.99万 - 项目类别:
Identification of 9p and 20q Germline Alterations in Glioblastoma Pathogenesis
胶质母细胞瘤发病机制中 9p 和 20q 种系改变的鉴定
- 批准号:
7937827 - 财政年份:2009
- 资助金额:
$ 9.99万 - 项目类别:
Molecular Markers of Glioma Initiation and Progression
神经胶质瘤发生和进展的分子标志物
- 批准号:
6756565 - 财政年份:2001
- 资助金额:
$ 9.99万 - 项目类别:
Molecular Markers of Glioma Initiation and Progression
神经胶质瘤发生和进展的分子标志物
- 批准号:
6496855 - 财政年份:2001
- 资助金额:
$ 9.99万 - 项目类别:
Molecular Markers of Glioma Initiation and Progression
神经胶质瘤发生和进展的分子标志物
- 批准号:
6607199 - 财政年份:2001
- 资助金额:
$ 9.99万 - 项目类别:
Molecular Markers of Glioma Initiation and Progression
神经胶质瘤发生和进展的分子标志物
- 批准号:
6926925 - 财政年份:2001
- 资助金额:
$ 9.99万 - 项目类别:
相似海外基金
Development of New Technologies at Roswell Park to Further Cancer-Based Research and Treatment Through Genome Modification
罗斯威尔公园开发新技术,通过基因组修饰进一步开展基于癌症的研究和治疗
- 批准号:
10733275 - 财政年份:2023
- 资助金额:
$ 9.99万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10701238 - 财政年份:2023
- 资助金额:
$ 9.99万 - 项目类别:
Preclinical-Clinical Trials Collaboration to effectively advance new combination therapies for malignant peripheral nerve sheath tumors
临床前-临床试验合作有效推进恶性周围神经鞘瘤的新联合疗法
- 批准号:
10393313 - 财政年份:2022
- 资助金额:
$ 9.99万 - 项目类别:
Preclinical-Clinical Trials Collaboration to effectively advance new combination therapies for malignant peripheral nerve sheath tumors
临床前-临床试验合作有效推进恶性周围神经鞘瘤的新联合疗法
- 批准号:
10662190 - 财政年份:2022
- 资助金额:
$ 9.99万 - 项目类别:
Identifying Microenvironmental Factors Regulating Melanoma Promotion and Immune Evasion
识别调节黑色素瘤促进和免疫逃避的微环境因素
- 批准号:
10188901 - 财政年份:2021
- 资助金额:
$ 9.99万 - 项目类别: